Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Lamictal Tablets &Chewable Dispersible Tablets (Lamotrigine)
Company:  Glaxo Wellcome, Inc.
Application No.:  020-241/S003 & 020-764/S001
Approval Date: 12/14/1998


Last updated: July 1, 2005

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.